AdhexPharma | AdhexPharma SAS

AdhexPharma is a full-service CDMO based in France and Germany, specialized in the development and manufacturing of transdermal and topical patches (TDS) as well as orodispersible and buccal films (ODF).

With over 40 years of experience in drug delivery technologies, we offer end-to-end solutions, from formulation and analytical development to clinical and commercial manufacturing, packaging, licensing and regulatory support.

Our facility produces over 100 million units annually, serving a diverse client base from emerging biotech to established pharmaceutical companies across Europe, North America, and selected international markets.

The site includes cleanroom manufacturing areas, pilot and industrial equipment, and dedicated R&D and QC laboratories, supporting both early-stage and large-scale production.

Our infrastructure spans more than 15,000 m² across four qualified buildings in France and Germany, and we are authorized to handle controlled substances.

We currently support a pipeline of 15+ development projects and offer out-licensing opportunities for proprietary drug delivery platforms.

Combining deep expertise in TDS and ODF technologies with a flexible, partnership-driven approach, AdhexPharma provides high-quality, integrated CDMO services to accelerate your drug development from idea to market.